Mergers & Acquisitions

A dramatic boardroom overhaul at pharmaceutical giant Novo Nordisk has cemented the controlling foundation's authority, triggering apprehension among minority shareholders...

Tesla has initiated one of its most significant operational shifts by instructing suppliers to eliminate all China-manufactured components from its...

The independent journey of Verve Therapeutics on public markets concluded on July 25, 2025, when the biotechnology firm was officially...

The pharmaceutical industry continues to scrutinize Vertex Pharmaceuticals' landmark acquisition of Alpine Immune Sciences, a transaction valued at $4.9 billion...

Jabil Inc. has positioned itself for substantial growth in the data center infrastructure sector through a landmark $725 million acquisition....

The chip design software leader Synopsys is navigating turbulent waters as it contends with multiple challenges simultaneously. While still integrating...

The American healthcare behemoth UnitedHealth is navigating the most severe crisis in its corporate history. As government antitrust probes intensify...

Eli Lilly and Company has positioned itself for substantial expansion through a series of strategic developments announced in early November...

The food industry giant Kraft Heinz is implementing its most drastic strategic maneuver—a corporate breakup—as it confronts a severe operational...

Iteris appears to be at a pivotal juncture following two significant strategic announcements. The company's recent acquisition and product launch...